Good morning, it's Wednesday! A few of us at STAT thought yesterday might have been Wednesday, but no, it's today. And in ...

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...

UnitedHealth Group and CVS Health have petitioned a judge to sideline FTC Chair Lina Khan from the agency’s lawsuit against ...

Two Chinese biotechs are testing CRISPR gene editing in boys with muscular dystrophy, even as projects at U.S. companies like ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

Opinion: An upcoming FDA ad comm on a treatment for the ultra rare Barth syndrome can’t use the normal measuring sticks for ...

Scholar Rock yesterday reported that its experimental treatment for spinal muscular atrophy succeeded in a Phase 3 trial, ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...

The billionaire co-founder of Mark Cuban Cost Plus Drugs said Tuesday that Harris "likes the idea of transparency, and she ...

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...

Scientific American editor-in-chief Laura Helmuth and opinion editor Megha Satyanarayana join "First Opinion Podcast" to discuss the magazine endorsing Kamala Harris.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...